Suppr超能文献

白细胞介素-6会加剧(新西兰黑鼠×新西兰白鼠)F1代小鼠的肾小球肾炎。

Interleukin-6 exacerbates glomerulonephritis in (NZB x NZW)F1 mice.

作者信息

Ryffel B, Car B D, Gunn H, Roman D, Hiestand P, Mihatsch M J

机构信息

Institute of Toxicology, Faculty of Medicine, University of Zurich, Switzerland.

出版信息

Am J Pathol. 1994 May;144(5):927-37.

Abstract

The ability of interleukin-6 (IL-6) to modulate immune parameters and mesangial cell function suggests a role for this cytokine in the development of autoimmune glomerulonephritis. This hypothesis was tested in 6-month-old female (NZB x NZW)F1 mice that were administered recombinant human IL-6 (rhIL-6) (50 and 250 micrograms/kg s.c.) for 12 weeks, resulting in an accelerated and severe form of membranoproliferative glomerulonephritis associated with marked upregulation of mesangial major histocompatibility complex class II antigen and glomerular ICAM-1 expression. To distinguish direct effects of rhIL-6 on the renal mesangium from those mediated through the immune system, (NZB x NZW)F1 mice were immunosuppressed with cyclosporin. Immunosuppression by cyclosporin inhibited the development of glomerulonephritis, decreased class II antigen expression, and abrogated IL-6-mediated effects. Administration of neutralizing anti-IL-6 antibody had no effect on the spontaneous development of glomerulonephritis in (NZB x NZW)F1 mice. This finding, together with undetectable IL-6 serum levels, makes a pathogenetic role of endogenously produced IL-6 in this disease model unlikely. In contrast to (NZB x NZW)F1 mice, parental NZW or BALB/c mice given high doses of rhIL-6 (500 micrograms/kg) or recombinant murine IL-6 (100 micrograms/kg) daily for 4 weeks failed to develop morphological or biochemical evidence of glomerulonephritis. Induction of acute phase proteins, anemia, thrombocytosis, and induction of renal class II antigen confirmed the biological activity of IL-6 in these mice. In conclusion, while non-nephritogenic in normal mice, IL-6 accelerates the development of the genetically determined glomerulonephritis of (NZB x NZW)F1 mice through effects mediated by a modulated immune system. Since neutralizing IL-6 antibody treatment did not prevent the development of glomerulonephritis, it is unlikely that increased IL-6 production plays a role in the pathogenesis of lupus nephritis.

摘要

白细胞介素-6(IL-6)调节免疫参数和系膜细胞功能的能力提示该细胞因子在自身免疫性肾小球肾炎的发生发展中起作用。在6月龄雌性(NZB×NZW)F1小鼠中对这一假说进行了验证,这些小鼠皮下注射重组人IL-6(rhIL-6)(50和250微克/千克),持续12周,导致出现加速且严重的膜增生性肾小球肾炎,伴有系膜主要组织相容性复合体II类抗原和肾小球细胞间黏附分子-1(ICAM-1)表达显著上调。为了区分rhIL-6对肾系膜的直接作用与通过免疫系统介导的作用,用环孢素对(NZB×NZW)F1小鼠进行免疫抑制。环孢素引起的免疫抑制抑制了肾小球肾炎的发展,降低了II类抗原表达,并消除了IL-6介导的作用。给予中和性抗IL-6抗体对(NZB×NZW)F1小鼠肾小球肾炎自发发展没有影响。这一发现,连同未检测到的IL-6血清水平,提示内源性产生的IL-6在该疾病模型中不太可能起致病作用。与(NZB×NZW)F1小鼠不同,给予高剂量rhIL-6(500微克/千克)或重组鼠IL-6(100微克/千克)、每日一次、持续4周的亲代NZW或BALB/c小鼠未出现肾小球肾炎的形态学或生化证据。急性期蛋白的诱导、贫血、血小板增多以及肾II类抗原的诱导证实了IL-6在这些小鼠中的生物学活性。总之,虽然IL-6在正常小鼠中不致肾炎,但它通过调节免疫系统介导的效应加速了(NZB×NZW)F1小鼠遗传性肾小球肾炎的发展。由于中和IL-6抗体治疗不能预防肾小球肾炎的发展,因此IL-6产生增加在狼疮性肾炎发病机制中不太可能起作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a94b/1887352/ba0c6c0f58e4/amjpathol00065-0090-a.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验